AW
ACAD icon

Avion Wealth’s Acadia Pharmaceuticals ACAD Stock Holding History

Avion Wealth’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+23
New +$506 ﹤0.01% 1397
2025
Q2 		– Sell
-63
Closed -$1K – 1108
2025
Q1 		$1K Hold
63
– – ﹤0.01% 792
2024
Q4 		$1K Buy
+63
New +$1.02K ﹤0.01% 789

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Avion Wealth's ACAD Position: Q2 2026 in Review

Avion Wealth opened a new position in Acadia Pharmaceuticals (ACAD) in Q2 2026: 23 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1397 among its holdings. This is a return to the name: Avion Wealth previously reported a position in ACAD as recently as Q1 2025.

Avion Wealth first reported a position in ACAD in Q4 2024 and has held it in 3 quarters since. The position peaked at $1K in Q1 2025. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Avion Wealth held 23 shares of Acadia Pharmaceuticals worth $0 as of Q2 2026.
  • Acadia Pharmaceuticals was a new Avion Wealth position in Q2 2026.
  • Acadia Pharmaceuticals made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #1397 holding.
  • Avion Wealth first reported a position in Acadia Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • Avion Wealth's Acadia Pharmaceuticals position peaked at $1K in Q1 2025.
  • 354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.